FR2482967A1 - Nouveaux derives de l'imidazo-rifamycine, leur procede de preparation et leur application en therapeutique - Google Patents

Nouveaux derives de l'imidazo-rifamycine, leur procede de preparation et leur application en therapeutique Download PDF

Info

Publication number
FR2482967A1
FR2482967A1 FR8110058A FR8110058A FR2482967A1 FR 2482967 A1 FR2482967 A1 FR 2482967A1 FR 8110058 A FR8110058 A FR 8110058A FR 8110058 A FR8110058 A FR 8110058A FR 2482967 A1 FR2482967 A1 FR 2482967A1
Authority
FR
France
Prior art keywords
existent
formula
rifamycin
hydrogen atom
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8110058A
Other languages
English (en)
French (fr)
Other versions
FR2482967B1 (cg-RX-API-DMAC7.html
Inventor
Egidio Marchi
Lauretta Montecchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfa Farmaceutici SpA
Original Assignee
Alfa Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Farmaceutici SpA filed Critical Alfa Farmaceutici SpA
Publication of FR2482967A1 publication Critical patent/FR2482967A1/fr
Application granted granted Critical
Publication of FR2482967B1 publication Critical patent/FR2482967B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR8110058A 1980-05-22 1981-05-20 Nouveaux derives de l'imidazo-rifamycine, leur procede de preparation et leur application en therapeutique Granted FR2482967A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Publications (2)

Publication Number Publication Date
FR2482967A1 true FR2482967A1 (fr) 1981-11-27
FR2482967B1 FR2482967B1 (cg-RX-API-DMAC7.html) 1985-03-29

Family

ID=11107198

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8110058A Granted FR2482967A1 (fr) 1980-05-22 1981-05-20 Nouveaux derives de l'imidazo-rifamycine, leur procede de preparation et leur application en therapeutique

Country Status (25)

Country Link
US (1) US4341785A (cg-RX-API-DMAC7.html)
JP (1) JPS5711987A (cg-RX-API-DMAC7.html)
AR (1) AR226212A1 (cg-RX-API-DMAC7.html)
AT (1) AT373599B (cg-RX-API-DMAC7.html)
AU (1) AU537093B2 (cg-RX-API-DMAC7.html)
BE (1) BE888895A (cg-RX-API-DMAC7.html)
CA (1) CA1142518A (cg-RX-API-DMAC7.html)
CH (1) CH648037A5 (cg-RX-API-DMAC7.html)
DE (1) DE3120460A1 (cg-RX-API-DMAC7.html)
DK (1) DK157876C (cg-RX-API-DMAC7.html)
EG (1) EG14891A (cg-RX-API-DMAC7.html)
ES (1) ES8203388A1 (cg-RX-API-DMAC7.html)
FI (1) FI69467C (cg-RX-API-DMAC7.html)
FR (1) FR2482967A1 (cg-RX-API-DMAC7.html)
GB (1) GB2079270B (cg-RX-API-DMAC7.html)
GR (1) GR75640B (cg-RX-API-DMAC7.html)
IE (1) IE51204B1 (cg-RX-API-DMAC7.html)
IT (1) IT1154655B (cg-RX-API-DMAC7.html)
LU (1) LU83376A1 (cg-RX-API-DMAC7.html)
NL (1) NL187022C (cg-RX-API-DMAC7.html)
NO (1) NO155622C (cg-RX-API-DMAC7.html)
PH (2) PH17207A (cg-RX-API-DMAC7.html)
PT (1) PT73064B (cg-RX-API-DMAC7.html)
SE (1) SE453089B (cg-RX-API-DMAC7.html)
ZA (1) ZA813430B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0161534A3 (en) * 1984-05-15 1987-03-04 Alfa Farmaceutici S.P.A. New process for the synthesis of pyrido-imidazo-refamycins

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264494B1 (it) * 1993-03-23 1996-09-24 Alfa Wassermann Spa Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
DE69829905T2 (de) * 1997-02-28 2006-03-09 Kaneka Corp. Heilmittel für durch Helicobacter verursachte Krankheit
EP1453837A4 (en) * 2001-11-21 2007-11-07 Activbiotics Inc TARGETED THERAPEUTIC AGENTS AND USES THEREOF
WO2003051299A2 (en) * 2001-12-13 2003-06-26 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
US8758804B2 (en) * 2002-11-05 2014-06-24 Fadim S.R.L. Controlled and continued delivery of rifaximin and/or other substances
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US7902206B2 (en) * 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
US7923553B2 (en) * 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
US7906542B2 (en) * 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
US20080262024A1 (en) * 2003-11-07 2008-10-23 Giuseppe Claudio Viscomi Rifaximin compositions and method of use
US7265107B2 (en) * 2004-03-10 2007-09-04 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
US7256187B2 (en) * 2004-03-10 2007-08-14 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
US7202246B2 (en) * 2004-06-09 2007-04-10 Cumbre Pharmaceuticals Inc. Spiro-rifamycin derivatives targeting RNA polymerase
US20060210492A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Use of rifaximin for treatment and prevention of periodontal conditions
US8003118B2 (en) * 2005-03-02 2011-08-23 Kodsi Robert E Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
US20060210483A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
PL1698630T3 (pl) 2005-03-03 2014-12-31 Alfasigma Spa Nowe postacie polimorficzne rifaksyminy,sposoby ich wytwarzania i ich zastosowanie w preparatach leczniczych
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
KR101327635B1 (ko) 2005-08-11 2013-11-12 타간타 테라퓨틱스 인크. 포스폰산화 리파마이신, 및 그의 뼈 및 관절 감염의 저지및 치료 용도
WO2007103448A2 (en) 2006-03-09 2007-09-13 Salix Pharmaceuticals, Inc. Rifaximin anti-rectal dysfunction preparation
EP2054066B1 (en) 2006-08-02 2015-04-15 Salix Pharmaceuticals, Inc. Methods for treatment of radiation enteritis
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
US8633234B2 (en) * 2006-09-22 2014-01-21 Cipla Limited Rifaximin
US20080161337A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Chronic Prostatitis
US20080159987A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Restless Legs Syndrome
ITMI20071241A1 (it) * 2007-06-20 2008-12-21 Solmag S P A Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
US8383151B2 (en) 2007-07-06 2013-02-26 Lupin Limited Pharmaceutical compositions of rifaximin
DK2011486T3 (da) 2007-07-06 2012-09-03 Lupin Ltd Farmaceutiske sammensætninger af rifaximin
US7709634B2 (en) * 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
KR101674382B1 (ko) * 2008-02-25 2016-11-09 샐릭스 파마슈티컬스 리미티드 리팍시민의 형태 및 이의 용도
US8486956B2 (en) 2008-02-25 2013-07-16 Salix Pharmaceuticals, Ltd Forms of rifaximin and uses thereof
MX2010009197A (es) 2008-02-26 2010-11-22 Salix Pharmaceuticals Ltd Metodos para tratar padecimientos del intestino.
US11779571B2 (en) 2008-02-26 2023-10-10 Salix Pharmaceuticals, Inc. Methods for treating irritable bowel syndrome (IBS)
PT2294012E (pt) 2008-05-07 2014-10-15 Salix Pharmaceuticals Ltd Administração de um agente de limpeza intestinal e de um antibiótico para o tratamento de doença intestinal
US8524691B2 (en) 2008-08-13 2013-09-03 The Medicines Company Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
PL2327407T3 (pl) 2008-09-26 2014-12-31 Alfasigma Spa Środek profilaktyczny i/lub terapeutyczny na zaburzenia czynnościowe przewodu pokarmowego
HRP20240317T1 (hr) 2008-10-02 2024-06-07 Salix Pharmaceuticals, Ltd. Liječenje hepatičke encefalopatije uporabom rifaksimina
US12285414B2 (en) 2008-10-02 2025-04-29 Salix Pharmaceuticals, Inc. Methods of treating hepatic encephalopathy
ES2718614T3 (es) 2008-12-10 2019-07-03 Cipla Ltd Complejos de rifaximina
IT1397617B1 (it) * 2009-04-20 2013-01-18 Alfa Wassermann Spa Nuovi derivati della rifamicina
KR20190099100A (ko) 2009-06-02 2019-08-23 샐릭스 파마슈티컬스 리미티드 간성 뇌병증의 치료방법
CA2773982C (en) 2009-09-13 2018-12-04 Salix Pharmaceuticals, Ltd. Methods for treating irritable bowel syndrome (ibs)
RU2012121599A (ru) 2009-10-27 2013-12-10 Люпин Лимитед Твердая дисперсия рифаксимина
EP2503989A2 (en) 2009-11-23 2012-10-03 Cipla Limited Topical foam composition
US8952159B2 (en) 2009-12-28 2015-02-10 Silvio Massimo Lavagna Method for the production of amorphous rifaximin
EP2536282A4 (en) 2010-02-18 2013-07-03 Salix Pharmaceuticals Ltd METHOD FOR THE TREATMENT OF INFECTIONS
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
AU2011225810B2 (en) 2010-03-10 2014-11-06 Lupin Limited Rifaximin ready-to-use suspension
SG10201505484RA (en) 2010-07-12 2015-09-29 Salix Pharmaceuticals Ltd Formulations of rifaximin and uses thereof
WO2012035544A2 (en) 2010-09-13 2012-03-22 Sequent Scientific Ltd. A novel polymorphic form of rifaximin and process for its preparation
PL2672970T3 (pl) 2011-02-11 2018-11-30 Salix Pharmaceuticals, Ltd. Postacie rifaksyminy i sposoby ich wykorzystania
AU2012251385A1 (en) 2011-05-02 2013-11-21 Ranbaxy Laboratories Limited Rifaximin dimethylformamide solvate
ITMI20110890A1 (it) 2011-05-19 2012-11-20 A M S A Anonima Materie Sint & Affini S P A Polimorfo di rifaximina e processo per la sua preparazione
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
RU2496475C2 (ru) 2011-10-26 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция и набор для лечения бактериальных инфекций
US20130184302A1 (en) 2011-11-02 2013-07-18 Enoch Bortey Methods for treating irritable bowel syndrome (ibs) and infections
WO2013112809A2 (en) 2012-01-25 2013-08-01 Salix Pharmaceuticals, Ltd Rifaximin derivative and uses thereof
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
WO2014091432A1 (en) 2012-12-12 2014-06-19 Ranbaxy Laboratories Limited Pharmaceutical compositions of rifaximin
CA2897758A1 (en) 2013-03-15 2014-09-18 Alfa Wassermann S.P.A. Rifaximin for use in the treating of vaginal infections
US20160047819A1 (en) 2013-03-15 2016-02-18 Alfa Wassermann S.P.A. Method for diagnosing vaginal infections
WO2014167533A1 (en) 2013-04-12 2014-10-16 Alfa Wassermann S.P.A. Nsaid administration and related compositions, methods and systems.
US9018225B1 (en) 2013-07-26 2015-04-28 Novel Laboratories Rifaximin crystalline forms and methods of preparation thereof
EP2927235B1 (en) 2014-03-31 2017-02-08 Euticals S.P.A. Polymorphic mixture of rifaximin and its use for the preparation of solid formulations
CA2946101A1 (en) * 2014-04-19 2015-10-22 Granules India Limited An improved process for the preparation of rifamycin derivatives
WO2015171493A1 (en) 2014-05-04 2015-11-12 Salix Pharmaceuticals, Inc. Ibs microbiota and uses thereof
PT3143027T (pt) 2014-05-12 2019-09-20 Alfasigma Spa Nova forma de cristal solvatado de rifaximina, produção, composições e utilização dos mesmos
EP2982764A1 (en) 2014-08-05 2016-02-10 ALFA WASSERMANN S.p.A. Identification of vaginal bacteria
US9988398B2 (en) 2016-06-07 2018-06-05 Cadila Healthcare Limited Crystalline form of rifaximin and process for its preparation
RS63751B1 (sr) 2016-09-30 2022-12-30 Salix Pharmaceuticals Inc Čvrsti disperzioni oblici rifaksimina
IT201700091912A1 (it) * 2017-08-08 2019-02-08 Biofer Spa Nuove pirido-imidazo rifamicine
RU2020102511A (ru) * 2017-06-26 2021-07-27 Биофер С.П.А. Соединения пиридо-имидазо рифамицина в качестве антибактериального средства

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2426690A2 (fr) * 1978-06-09 1979-12-21 Archifar Lab Chim Farm Composes de rifamycine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE273377C (cg-RX-API-DMAC7.html) *
AT273377B (de) * 1967-03-01 1969-08-11 Lepetit Spa Verfahren zur Herstellung von neuen Rifamycinen
AT344898B (de) * 1975-06-13 1978-08-10 Archifar Ind Chim Trentino Verfahren zur herstellung neuer rifamycin-verbindungen
DK345977A (da) * 1976-09-30 1978-03-31 Archifar Ind Chim Trentino G rifamycinforbindelser og fremgangsmaade til deres fremstillin
CH629212A5 (it) * 1976-10-18 1982-04-15 Erba Farmitalia Procedimento per la preparazione di composti di rifamicina.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2426690A2 (fr) * 1978-06-09 1979-12-21 Archifar Lab Chim Farm Composes de rifamycine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0161534A3 (en) * 1984-05-15 1987-03-04 Alfa Farmaceutici S.P.A. New process for the synthesis of pyrido-imidazo-refamycins

Also Published As

Publication number Publication date
FI811565L (fi) 1981-11-23
NL8102290A (nl) 1981-12-16
PH17207A (en) 1984-06-19
SE453089B (sv) 1988-01-11
JPS5711987A (en) 1982-01-21
CA1142518A (en) 1983-03-08
IE811139L (en) 1981-11-22
BE888895A (fr) 1981-09-16
DK224781A (da) 1981-11-23
LU83376A1 (fr) 1981-09-11
NO811731L (no) 1981-11-23
NL187022B (nl) 1990-12-03
DK157876B (da) 1990-02-26
PT73064B (en) 1982-07-05
SE8103216L (sv) 1981-11-23
PT73064A (en) 1981-06-01
GB2079270B (en) 1984-01-18
AU7065581A (en) 1981-11-26
NO155622B (no) 1987-01-19
IE51204B1 (en) 1986-10-29
FI69467C (fi) 1986-02-10
AR226212A1 (es) 1982-06-15
IT8003429A0 (it) 1980-05-22
ATA222781A (de) 1983-06-15
FI69467B (fi) 1985-10-31
GB2079270A (en) 1982-01-20
ZA813430B (en) 1982-06-30
ES502906A0 (es) 1982-04-01
CH648037A5 (de) 1985-02-28
PH18704A (en) 1985-09-05
US4341785A (en) 1982-07-27
GR75640B (cg-RX-API-DMAC7.html) 1984-08-02
EG14891A (en) 1985-12-31
IT1154655B (it) 1987-01-21
AU537093B2 (en) 1984-06-07
DE3120460C2 (cg-RX-API-DMAC7.html) 1990-12-13
NL187022C (nl) 1991-05-01
DK157876C (da) 1990-07-30
NO155622C (no) 1987-04-29
FR2482967B1 (cg-RX-API-DMAC7.html) 1985-03-29
JPS6123192B2 (cg-RX-API-DMAC7.html) 1986-06-04
DE3120460A1 (de) 1982-03-11
AT373599B (de) 1984-02-10
ES8203388A1 (es) 1982-04-01

Similar Documents

Publication Publication Date Title
FR2482967A1 (fr) Nouveaux derives de l'imidazo-rifamycine, leur procede de preparation et leur application en therapeutique
EP0036812B1 (fr) Nouveaux dérivés des céphalosporines, leur procédé de préparation et les médicaments utilisables comme antibiotiques qui contiennent lesdits dérivés
BE851310A (fr) Nouveaux derives de la tetrahydro-equinocandine b
EP0253738A1 (fr) Dérivés du taxol, leur préparation et les compositions pharmaceutiques qui les contiennent
FR2477016A1 (fr) Compositions pharmaceutiques a base de derives de mitomycine pour le traitement de maladie neoplastique chez les animaux
FR2676738A1 (fr) Nouveau derive organique de metal de transition a structure porphyrinique, composition therapeutique le contenant, en particulier a activite hypoglycemiante.
CH638221A5 (fr) Oximes derivees de l'acide 3-substitue 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et les compositions pharmaceutiques les renfermant.
EP0533827B1 (fr) Nouveaux derives de l'oxazole, leur preparation et les compositions pharmaceutiques qui les contiennent
CA1094547A (fr) Procede de preparation de derives de l'acide 3- carbamoyloxymethyl 7-(amino thiazolyl acetamido) cephalosporanique
EP0044238B1 (fr) Dérivés de céphalosporines sulfoxydes, procédé de préparation et compositions pharmaceutiques en contenant
EP0061397B1 (fr) Nouveaux dérivés solubles N2 substitués de la diamino-2,4-benzyl-5-pyrimidines, leur procédé de préparation et médicaments les contenant
FR2502627A1 (fr) Derives thioliques de l'erythromycine a activite therapeutique, procede de preparation et produits pharmaceutiques dans lesquels ils apparaissent
FR2474503A1 (fr) Composes intermediaires utiles pour l'obtention de la spectinomycine et de ses analogues ainsi que l'utilisation de ces produits
CH626088A5 (en) Process for the preparation of new oximes derived from 3-carbamoyloxymethyl-7-(aminothiazolylacetamido)cephalosporanic acid
FR2519988A1 (fr) Derives thioliques de l'erythromycine a activite therapeutique, procede de preparation et produits pharmaceutiques dans lesquels ils apparaissent
FR2492385A1 (fr) Nouveaux composes cytostatiques derives de la vinblastine, leur procede de preparation et composition pharmaceutique les contenant
FR2492384A1 (fr) Procede de preparation de nouveaux composes cytostatiques et compositions pharmaceutiques les contenant
WO1996004299A1 (fr) Derives de streptogramine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2591598A1 (fr) Nouveaux derives d'acide ceph-3-em-4-carboxylique, leur preparation et medicaments les contenant
EP0269512B1 (fr) Dérivés des céphalosporines à pharmacocinétique améliorée, procédé pour leur préparation et compositions pharmaceutiques les contenant
FR2504134A1 (fr) Nouveaux derives du nitroimidazole, un procede pour leur preparation et compositions therapeutiques trichomonoacides en contenant
BE887456R (fr) Procede de production de composes intermediaires pour l'obtention de la spectinomycine et de ses analogues et produits de ce procede
BE876466A (fr) Derive de l'acide penicillanique et son procede de preparation
KR20010029475A (ko) 약제학적 화합물의 제조 방법
CH631461A5 (en) Semi-synthetic derivatives of 4''-sulphonylaminooleandomycin